This review summarizes recent advances in liposomal nanoparticle-based drug delivery systems aimed at improving therapeutic outcomes in multiple myeloma.
Hanafy et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: